Erratum to Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes, [Toxicological Sciences, 2009; 110: 61-67, 10.1093/toxsci/kfp079];Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes

Toxicological Sciences

Volumn 110, Issue 1, 2009, Pages 61-67

  Beedanagari, Sudheer R ^a   Bebenek, Ilona ^a   Bui, Peter ^a   Hankinson, Oliver ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ChIP assay; CYP1A1; CYP1B1; Dioxin; Resveratrol

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIOXIN; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; RESVERATROL; RNA POLYMERASE II;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG MECHANISM; ENHANCER REGION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOBIOTIC METABOLISM;

EID: 67649221173     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq145     Document Type: Erratum

References (32)

1. Aluru, N., and Vijayan, M. M. (2006). Resveratrol affects CYP1A expression in rainbow trout hepatocytes. Aquat. Toxicol. 77, 291-297.
2. Aziz, M. H., Kumar, R., and Ahmad, N. (2003). Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23, 17-28.
3. Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E., and Savouret, J. F. (1999). Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol. Pharmacol. 56, 784-790.
4. Chang, T. K., Chen, J., and Lee, W. B. (2001). Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: Evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299, 874-882.
5. Chang, T. K., Lee, W. B., and Ko, H. H. (2000). Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can. J. Physiol. Pharmacol. 78, 874-881.
6. Chen, Z. H., Hurh, Y. J., Na, H. K., Kim, J. H., Chun, Y. J., Kim, D. H., Kang, K. S., Cho, M. H., and Surh, Y. J. (2004). Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 25, 2005-2013.
7. Chun, Y. J., Kim, M. Y., and Guengerich, F. P. (1999). Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun. 262, 20-24.
8. Ciolino, H. P., Daschner, P. J., and Yeh, G. C. (1998). Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 58, 5707-5712.
9. Ciolino, H. P., and Yeh, G. C. (1999). Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56, 760-767.
10. Ciolino, H. P., and Yeh, G. C. (2001). The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro. Adv. Exp. Med. Biol. 492, 183-193.
11. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
12. Hsu, E. L., Yoon, D., Choi, H. H., Wang, F., Taylor, R. T., Chen, N., Zhang, R., and Hankinson, O. (2007). A proposed mechanism for the protective effect of dioxin against breast cancer. Toxicol. Sci. 98, 436-444.
13. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 218-220.
14. Jayatilake, G. S., Jayasuriya, H., Lee, E. S., Koonchanok, N. M., Geahlen, R. L., Ashendel, C. L., McLaughlin, J. L., and Chang, C. J. (1993). Kinase inhibitors from Polygonum cuspidatum. J. Nat. Prod. 56, 1805-1810.
15. Khan, N., Afaq, F., and Mukhtar, H. (2008). Cancer chemoprevention through dietary antioxidants: Progress and promise. Antioxid. Redox. Signal. 10, 475-510.
16. Köhle, C., and Bock, K. W. (2006). Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. Biochem. Pharmacol. 72, 795-805.
17. Kress, S., and Greenlee, W. F. (1997). Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57, 1264-1269.
18. Le Corre, L., Chalabi, N., Delort, L., Bignon, Y. J., and Bernard-Gallon, D. J. (2005). Resveratrol and breast cancer chemoprevention: Molecular mechanisms. Mol. Nutr. Food Res. 49 462-471.
19. Lee, J. E., and Safe, S. (2001). Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells. Biochem. Pharmacol. 62, 1113-1124.
20. Liu, J., Wang, Q., Wu, D. C., Wang, X. W., Sun, Y., Chen, X. Y., Zhang, K. L., and Li, H. (2004). Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells. Neurosci. Lett. 363, 257-261.
21. Mikstacka, R., Baer-Dubowska, W., Wieczorek, M., and Sobiak, S. (2008). Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities. Mol. Nutr. Food Res. 52, 77-83.
22. Mikstacka, R., Przybylska, D., Rimando, A. M., and Baer-Dubowska, W. (2007). Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol. Nutr. Food Res. 51, 517-524.
23. Mollerup, S., Ovrebo, S., and Haugen, A. (2001). Lung carcinogenesis: Resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int. J. Cancer 92 18-25.
24. Piver, B., Berthou, F., Dreano, Y., and Lucas, D. (2001). Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol. Lett. 125, 83-91.
25. Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J., Butler, P. C., Ijaz, T., Ruparelia, K. C., Lamb, J. H., Farmer, P. B., Stanley, L. A., et al. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86, 774-778.
26. Probst, M. R., Reisz-Porszasz, S., Agbunag, R. V., Ong, M. S., and Hankinson, O. (1993). Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44, 511-518.
27. Rendic, S. (2002). Summary of information on human CYP enzymes: Human P450 metabolism data. Drug Metab. Rev. 34, 83-448.
28. Signorelli, P., and Ghidoni, R. (2005). Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises. J. Nutr. Biochem. 16, 449-466.
29. Stewart, J. R., Artime, M. C., and O'Brian, C. A. (2003). Resveratrol: A candidate nutritional substance for prostate cancer prevention. J. Nutr. 133, 2440S-2443S.
30. Taylor, R. T., Wang, F., Hsu, E. L., and Hankinson, O. (2009). Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells. Toxicol. Sci. 107, 1-8.
31. Whitsett, T. G., Jr., and Lamartiniere, C. A. (2006). Genistein and resveratrol: Mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev. Anticancer Ther. 6, 1699-1706.
32. Wu, M. L., Li, H., Wu, D. C., Wang, X. W., Chen, X. Y., Kong, Q. Y., Ma, J. X., Gao, Y., and Liu, J. (2005). CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis. Neurosci. Lett. 384, 33-37.